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A B S T R A C T
Introduction: Caroli syndrome is characterized as multiple cystic or saccular dilatations of intrahe-
patic bile ducts (Caroli disease) and congenital hepatic ﬁbrosis. Diagnosis depends on histological features
and imaging, which shows communications between the sacculi and bile ducts.
Presentation of a case: In our case, the patient had segments II/III liver resection six years ago for Caroli
syndrome. A follow-up CT after four months of the operation revealed remnant cysts in segment IV, which
needed another surgical intervention to resect the remnant cysts and segment IV after six years from
the ﬁrst operation.
Disscussion: In our case, we were surprised that patient has remnant of the primary benign disease in
the follow-up CT after only four months of the previous operation. This remnant continued to increase
in size with recurrent attacks of cholangitis until liver abscess developed and required another surgical
intervention.
Conclusion: Imaging is essential in planning the operative treatment to detect the extent of the Caroli
disease and deﬁne the extent of resection. Any residual disease due to inappropriate imaging planning
may cost the patient another cycle of suffering and may need another surgical intervention as in our case.
We recommend using intraoperative ultrasound for accurate determination of the line of resection.
© 2016 Published by Elsevier Ltd on behalf of Surgical Associates Ltd. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Caroli syndrome is a rare inherited autosomal recessive disor-
der with prevalence of 1 in 1,000,000 of the population [1]. It is a
developmental anomaly consisting of multiple cystic or saccular di-
latation of intrahepatic bile ducts (Caroli disease) and congenital
hepatic ﬁbrosis, which refers to unique bland portal ﬁbrosis, hyper
proliferation of interlobar bile ducts and preservation of normal
lobular architecture [2].
There aremany theories explaining its pathogenesis. Themost ac-
ceptable theory is remodeling of the embryologic bile duct plate of
the larger intrahepatic bile ducts resulting in destructive inﬂamma-
tion of the bile ducts,which then enlarge, dilate, and become ecstatic
either focally, segmentally or in a lobar fashion [3,4]. Caroli syn-
dromemaybe associatedwith autosomal recessive polycystic kidney
and occasionally with autosomal dominant kidney disease [5].
The presentation of Caroli syndrome is not uniform and depends
on the amount of liver involved and progression of decompensa-
tion [6,7]. Beside the possible renal complications, biliary obstruction
and repeated cholangitis result in morbidity and mortality [8].
There are about 250 published cases of Caroli disease and syn-
drome, but our case is the ﬁrst one that reported a patient needed
a second operation (liver resection) due to remnant intrahepatic
biliary cysts which enlarged after six years and developed into liver
abscess with recurrent attacks of cholangitis.
2. Presentation of a case
A 54-year-old Asian female patient was referred to a second-
ary level hospital, diagnosed with liver abscess at the site of previous
liver resection (left lateral segmentectomy) six years ago due to Caroli
syndrome in segments II and III. She had ﬁve-year symptoms-free
period after the ﬁrst operation. A year later, patient started to develop
repeated attacks of upper abdominal pain and fever. Abdominal ul-
trasound revealed a cystic lesion at the site of the previous operation
with turbid ﬂuid inside. Computed tomography guided aspiration
from the lesion revealed a turbid infected ﬂuid, and then 10-F-
drain was applied. Antibiotics were given and the patient was
referred to our hospital.
At our hospital, we reviewed the old imaging and laboratory in-
vestigations, and discovered that follow-up CT after 4 months of the
previous operation showed remnant saccular dilations in segment
IV (Fig. 1).
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New ultrasound and abdominal CT revealed a cystic septated
lesion (47 × 58 × 43mm) in segment IV (Fig. 2). MRCP showed mul-
tiple cystic dilatations through the biliary tract (Fig. 3).
Lab ﬁndings included white blood count (13.400/L), Hb (7.7g/dl),
platelets (294.000), INR (1.1), ALT (12.70 μmol/l), AST (13.08 μmol/l),
Alkaline phosphatase (3.09 μmol/l), gamma-GT (24.37 μmol/l), CRP
(82.5 mg/l), total bilirubin (74 μmol/l) and CA19-9 (1053 U/ml).
During surgery, we found a big cystic lesion in segment IV ﬁrmly
adherent to the stomach, diaphragm and anterior abdominal wall.
After intraoperative ultrasound, we conﬁrmed that the lesion was
not extended to right liver lobe and conﬁned to segment IV. We
decided to resect segment IV with tangential resection of adher-
ent part of the stomach. The postoperative period was normal and
patient discharged after eleven days. Pathologic examination of the
liver revealed dilated irregular biliary ductules with hepatic ﬁbro-
sis with no evidence of malignancy, with 2 cm free cut margin.
3. Discussion
In 1958, Caroli and Couinaud described congenital intrahe-
patic biliary cystic disease [9]. Later, Barros conﬁrmed two basic
types: one manifests simply with cystic intrahepatic bile ducts and
another associated with hepatic ﬁbrosis [10].
Caroli disease or syndrome are divided into two types: local-
ized and diffuse. The localized formwhichmostly involves the entire
left lobe of the liver is the most frequent form [11].
Clinical presentation of Caroli syndrome is variable. Symptoms
may appear early or late during life. Cholangitis dominates the clin-
ical course and is considered to be the principal cause of morbidity
and mortality and may lead to chronic abdominal pain, pancreati-
tis and liver abscess. The most serious complication of Caroli
syndrome is development of bile duct carcinoma which is diag-
nosed as incidental ﬁnding in pathologic examination [12].
In our case, we were surprised that the patient had remnant of
the primary benign disease in the follow-up CT after only four
months of the previous operation, which was attributed to incom-
plete removal of the lesion in the ﬁrst operation due to dependence
only on clinical sense without planning of the resection line by in-
traoperative US. This remnant continued to increase in size with
recurrent attacks of cholangitis until liver abscess developed and
required another surgical intervention.
4. Conclusion
Intraoperative imaging is essential in planning the operative treat-
ment to detect the extent of the Caroli disease and deﬁne the extent
of resection. Any residual disease even in benign lesions like our
case due to inappropriate imaging planning may cost the patient
another cycle of suffering and may need another surgical interven-
tion as in our case. We recommend using intraoperative ultrasound
for accurate determination of the line of resection in all lesions even
in benign diseases.
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Fig. 1. Follow-up CT after four months of the ﬁrst resection showing remnant cystic
lesion in segment IV.
Fig. 2. CT after ﬁve years after the ﬁrst resection showing dilated cystic lesion in
segment IV (patient suffered from recurrent attacks, upper abdominal pain and fever).
Fig. 3. MR imaging shows multiple cystic dilatations throughout the biliary
tract.
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